LinkedIn Profile

Access New Health Sciences historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:newhealthsciences 147147 May 30th, 2019 12:00AM New Health Sciences, Inc. 1.2K 13.00 Open Medical Devices May 30th, 2019 01:56PM May 30th, 2019 01:56PM New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants. Open Medical Devices, Medical Device R&D, Blood Management, Blood Products, Clinical Research, Blood Collection, Blood Storage, Medical Device Management, Transfusion Medicine, Biomechanical Innovation 245 First Street, Suite 1800 Cambridge MA US 02142 New Health Sciences Health Care Equipment & Services
private:newhealthsciences 147147 Mar 19th, 2018 12:00AM New Health Sciences, Inc. 1.2K 14.00 Open Medical Devices Mar 19th, 2018 07:30AM Mar 19th, 2018 07:30AM Open New Health Sciences Health Care Equipment & Services
private:newhealthsciences 147147 Feb 17th, 2018 12:00AM New Health Sciences, Inc. 1.2K 20.00 Open Medical Devices Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants. New Health Sciences Health Care Equipment & Services
private:newhealthsciences 147147 Feb 16th, 2018 12:00AM New Health Sciences, Inc. 1.2K 20.00 Open Medical Devices Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants. New Health Sciences Health Care Equipment & Services
private:newhealthsciences 147147 Feb 15th, 2018 12:00AM New Health Sciences, Inc. 1.2K 20.00 Open Medical Devices Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants. New Health Sciences Health Care Equipment & Services
private:newhealthsciences 147147 Feb 14th, 2018 12:00AM New Health Sciences, Inc. 1.2K 20.00 Open Medical Devices Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants. New Health Sciences Health Care Equipment & Services
private:newhealthsciences 147147 Feb 13th, 2018 12:00AM New Health Sciences, Inc. 1.2K 20.00 Open Medical Devices Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants. New Health Sciences Health Care Equipment & Services
private:newhealthsciences 147147 Feb 12th, 2018 12:00AM New Health Sciences, Inc. 1.2K 20.00 Open Medical Devices Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants. New Health Sciences Health Care Equipment & Services
private:newhealthsciences 147147 Feb 11th, 2018 12:00AM New Health Sciences, Inc. 1.2K 20.00 Open Medical Devices Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants. New Health Sciences Health Care Equipment & Services
private:newhealthsciences 147147 Feb 10th, 2018 12:00AM New Health Sciences, Inc. 1.2K 20.00 Open Medical Devices Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM New Health Sciences is developing Hemanext, a technology designed to improve the safety and efficacy of transfusion therapy through novel storage methods potentially extending the shelf life of refrigerated red blood cells while improving their quality across the storage cycle. NHSi has financed development of the Hemanext technology through private investor funding and a series of NIH SBIR grants. New Health Sciences Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.